What The Study Did: Researchers analyzed changes in filled prescriptions for naloxone (medication to reverse opioid overdoses) during the COVID-19 pandemic in the United States and compared them with changes in opioid prescriptions and overall prescriptions.
Authors: Ashley L. O'Donoghue, Ph.D., of the Beth Israel Deaconess Medical Center in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https:/
About JAMA Heath Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.